Director/PDMR Shareholding

RNS Number : 7631A

Epistem Holdings plc

03 April 2012

 



Epistem Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 285 ordinary shares of 1.5p each. These shares were acquired on 24 January 2012, 16 February 2012 and 29 March 2012 at prices of 360p, 408p and 412p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                             9,250                                   0.10%

Dr Catherine Booth                  983,605                                  11.11%

Dr Jeffrey Moore                        15,930                                   0.18%

John Rylands                            193,503                                    2.19%

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel / Vijay Barathan                                                     [phone]

 

END

 

 

RDSBUGDSSSGBGDX